Pénichoux, J., Cheze, S., Najar, W., Camus, V., Leveque, E., Jardin, F., Lepretre, S., Dubois, S., Lemasle, E., Menard, A., David, M., Alani, M., Contentin, N., Bouclet, F., Lenain, P., Brehar, O., Pouaty, C., Lanic, H., Lebreton, P., Zduniak, A., Fruchart, C., Groza, L., Bastard, A. S. (2025). Evaluation of levofloxacine as antibiotic prophylaxis in MDS and AML patients treated with azacitidine: Results from the randomized open-label phase III azabac study. Blood. https://doi.org/10.1182/blood-2025-3846